New listings
Maze TherapeuticsMAZE
ListedNasdaq
Road to listing
- Filed (S-1)25/01/07
- 2 amendments25/01/30Last amendment
- Declared effective25/01/30
- Priced25/01/30
- Listed25/01/31
- Lock-up ends25/07/30Passed
Offering terms
- Offer price
- $16.00
- Shares offered
- 8,750,000 sh
- Raised
- $140M
- Exchange
- Nasdaq
- Lock-up
- 180 days · prospectus
Maze Therapeutics stock pagePrice and every trade
5% holders
| Form | ||||
|---|---|---|---|---|
| 9.4% | 4,120,053 sh | 13G passive | 25/05/15 | |
| 9.3% | 4,473,958 sh | 13G passive | 02/13 | |
| 9.0% | 3,948,910 sh | 13G passive | 25/08/14 | |
| 9.0% | 4,342,266 sh | 13G passive | 02/13 | |
| 5.8% | 2,858,876 sh | 13G passive | 05/15 | |
| 5.4% | 2,978,114 sh | 13G passive | 07/29 | |
| 3.5% | 1,653,684 sh | 13G passive | 25/11/13 | |
| 2.9% | 1,388,583 sh | 13G passive | 02/06 | |
| 1.4% | 608,948 sh | 13G passive | 25/11/14 | |
| 0.0% | 0 sh | 13G passive | 08/14 |
22 planned sale notices (Form 144) by this company's insiders
Filings
- EFFECT notice of effectiveness05/13
- S-1 registration statement25/10/17
- 424B4 final prospectus25/01/31
- EFFECT notice of effectiveness25/01/30
- S-1/A amendment25/01/30
- 8-A12B exchange registration25/01/27
- S-1/A amendment25/01/27
- S-1 registration statement25/01/07